Thrombus in the left atrial appendage (LAA) contributes to 90% of atrial fibrillation (AF)-
related strokes. 1 Whether it is the result of low flow state, the presence of scar tissue, or …

It is well established that patients with atrial fibrillation (AF) have a significantly increased
risk of stroke and systemic embolism (SSE). Treatment with oral anticoagulation (OAC) …

Left atrial appendage occlusion (LAAO) has emerged as an effective site-directed therapy in
patients with nonvalvular atrial fibrillation (AF) for stroke prevention, who are ineligible for …

Atrial fibrillation (AF) is the most common arrhythmia affecting more than 1.6 million patients
in Germany. Based on demographic developments, an the number is expected to increase …

Clinicians are often faced with a challenging clinical scenario regarding the management of
stroke risk in patients with atrial fibrillation (AF) who have elevated bleeding risk. When …

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and associated with
an elevated risk of thromboembolic stroke and systemic embolization. The evidence …

With great interest we read the EHRA/EAPCI expert consensus statement on catheter-based
left atrial appendage (LAA) occlusion. 1 It is important to emphasize that the seminal efforts …

Strokes resulting from embolization of left atrial appendage (LAA) thrombi in patients with
atrial fibrillation (AF) account for up to 25% of the 700,000 cerebrovascular accidents …

An appropriately cautious uptake of left atrial appendage closure (LAAC) has followed from
early randomized trial evidence. In the PROTECT-AF 1 and PREVAIL 2 trials, LAAC was …

The purpose of this EP Wire was to assess the indications, techniques, and outcomes of left
atrial appendage occlusion (LAAO) in Europe. Thirty-three European centres, all members …